Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
July 27, 2012
BrainStorm Cell Therapeutics raises a $206,910 seed round.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
BrainStorm Cell Therapeutics halfCway through enrolling its Phase 3 ALS study
Christine Corrado
Web
BrainStorm Cell Therapeutics halfway through enrolling its Phase 3 ALS study
January 11, 2019
Brainstorm Cell Therapeutics updates on its progressive MS drug development trials
February 12, 2019
News
Title
Author
Date
Publisher
Description
Brainstorm Cell Therapeutics Inc
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
Heather McKenzie
May 4, 2021
BioSpace
There is also a tacit acknowledgment in the industry that the ALSFRS-R (revised) scale needs to evolve.
Brainstorm Cell Therapeutics Inc
April 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...
Nick Paul
March 24, 2021
FierceBiotech
BrainStorm Cell Therapeutics has presented phase 2 data on its stem cell therapy in patients with multiple sclerosis. The small, open-label clinical trial linked autologous therapy NurOwn to a 25% improvement in measures of mobility and dexterity in around 14% of patients.
Pomerantz LLP
March 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. ("Brainstorm" or the "Company") (NASDAQ:...
SHOW MORE
References
5
Type: Web page
https://ir.brainstorm-cell.com/stock-quote6
Type: Web page
https://cage.report/CAGE/8M4U47
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude8
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude9
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude